Enter assignee name

EPO Patents = 3

Trademarks = 2

Forward Citations = 44

Loading Chart...

4 inventors (with patents filed for the assignee):

David M Hilbert (9 out of 26 patents)

Jeffrey S Swers (7 out of 11 patents)

David William Lafleur (7 out of 16 patents)

4. Justin Edwards (2 out of 2 patents)

11 patents: Sort by Forward Citations

1. 12421291 - D-domain containing polypeptides and uses thereof (2025-09-23),

2. 12358995 - De novo binding domain containing polypeptides and uses thereof (2025-07-15),

3. 12338294 - D-domain containing polypeptides and uses thereof (2025-06-24),

4. 11827716 - D-domain containing polypeptides and uses thereof (2023-11-28),

5. 11730763 - Multifunctional immune cell therapies (2023-08-22),

6. 11464803 - D-domain containing polypeptides and uses thereof (2022-10-11),

7. 11377482 - D-domain containing polypeptides and uses thereof (2022-07-05),

8. 11318165 - D-domain containing polypeptides and uses thereof (2022-05-03),

9. 11008397 - De novo binding domain containing polypeptides and uses thereof (2021-05-18),

10. 10662248 - De novo binding domain containing polypeptides and uses thereof (2020-05-26),

11. 10647775 - De novo binding domain containing polypeptides and uses thereof (2020-05-12),

Arcellx is a biotechnology company focused on developing innovative cell therapies for cancer. The company's proprietary SynthorinTM technology platform enables the design and engineering of highly specific immune cells to target and destroy cancer cells. Arcellx is committed to bringing life-changing therapies to patients with unmet medical needs.

This text is generated by artificial intelligence and may not be accurate.